Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Venetoclax |
BCL-2 Inhibitor | Hematologic | ||
|
Molecule
Venetoclax
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
||||
Navitoclax |
BCL-2 Inhibitor | Hematologic | ||
|
Molecule
Navitoclax
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
||||
Obatoclax |
BCL-2 Inhibitor | Hematologic | ||
|
Molecule
Obatoclax
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
||||
Lisaftoclax |
BCL-2 Inhibitor | Hematologic | ||
|
Molecule
Lisaftoclax
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
||||
Sonrotoclax |
BCL-2 Inhibitor | Hematologic | ||
|
Molecule
Sonrotoclax
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
||||
APG-2575 (Lisaftoclax) |
BCL-2 Inhibitor | Hematologic | ||
|
Molecule
APG-2575 (Lisaftoclax)
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
||||
Selinexor |
XPO1 (Exportin-1) Inhibitor | Hematologic (Multiple Myeloma/DLBCL) | ||
|
Molecule
Selinexor
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (Multiple Myeloma/DLBCL)
Drug Class / Mechanism
XPO1 (Exportin-1) Inhibitor |
||||
Eltanexor |
XPO1 (Exportin-1) Inhibitor | Hematologic (Multiple Myeloma/DLBCL) | ||
|
Molecule
Eltanexor
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (Multiple Myeloma/DLBCL)
Drug Class / Mechanism
XPO1 (Exportin-1) Inhibitor |
||||
Epoetin Alfa |
Erythropoiesis-Stimulating Agent | Hematologic (Anemia) | ||
|
Molecule
Epoetin Alfa
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Anemia)
Drug Class / Mechanism
Erythropoiesis-Stimulating Agent |
||||
Epoetin Beta |
Erythropoiesis-Stimulating Agent | Hematologic (Anemia) | ||
|
Molecule
Epoetin Beta
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Anemia)
Drug Class / Mechanism
Erythropoiesis-Stimulating Agent |
||||
Darbepoetin Alfa |
Erythropoiesis-Stimulating Agent | Hematologic (Anemia) | ||
|
Molecule
Darbepoetin Alfa
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Anemia)
Drug Class / Mechanism
Erythropoiesis-Stimulating Agent |
||||
Methoxy Polyethylene Glycol-Epoetin Beta |
Erythropoiesis-Stimulating Agent | Hematologic (Anemia) | ||
|
Molecule
Methoxy Polyethylene Glycol-Epoetin Beta
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Anemia)
Drug Class / Mechanism
Erythropoiesis-Stimulating Agent |
||||
VenetoclaxTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
|
NavitoclaxTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
|
ObatoclaxTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
|
LisaftoclaxTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
|
SonrotoclaxTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
|
APG-2575 (Lisaftoclax)Targeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
BCL-2 Inhibitor |
|
SelinexorTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (Multiple Myeloma/DLBCL)
Drug Class / Mechanism
XPO1 (Exportin-1) Inhibitor |
|
EltanexorTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (Multiple Myeloma/DLBCL)
Drug Class / Mechanism
XPO1 (Exportin-1) Inhibitor |
|
Epoetin AlfaSupportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Anemia)
Drug Class / Mechanism
Erythropoiesis-Stimulating Agent |
|
Epoetin BetaSupportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Anemia)
Drug Class / Mechanism
Erythropoiesis-Stimulating Agent |
|
Darbepoetin AlfaSupportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Anemia)
Drug Class / Mechanism
Erythropoiesis-Stimulating Agent |
|
Methoxy Polyethylene Glycol-Epoetin BetaSupportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Anemia)
Drug Class / Mechanism
Erythropoiesis-Stimulating Agent |
|